Machine learning screens cinnamic-acid derivatives for Leishmania enzyme inhibition
Two random-forest classifiers and docking ranked an in-house set of cinnamic-acid derivatives; selected compounds were tested against recombinant L. major DHFR-TS. The paper reports IC50 values of 7.5, 6.1 and 10.1 µM for three named natural products versus 1.4 µM for methotrexate. These are enzyme assays, not whole-parasite treatment results.
Technology: Random-forest classifiers; structure-based docking
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: direct test
- Tested: Primary article reports recombinant DHFR-TS inhibition for selected compounds and comparator.
- Still unknown: Methods/results disagree on number of compounds; name/formula spellings and exact prior art need checking.
- AI role: RF models and docking prioritize a small compound set for biochemical enzyme assays.
Evidence sources: https://doi.org/10.3390/molecules29010179
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 16 Nov 2026. Review scope: PMC-hosted primary full text; publisher primary article page. Material checked for the specific claims stated in the record..
Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.